Sales rise 19.47% to Rs 484.80 crore
Net profit of Alembic Pharmaceuticals rose 53.92% to Rs 63.83 crore in the quarter ended September 2013 as against Rs 41.47 crore during the previous quarter ended September 2012. Sales rose 19.47% to Rs 484.80 crore in the quarter ended September 2013 as against Rs 405.80 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales484.80405.80 19 OPM %19.5815.66 -PBDT92.5360.65 53 PBT82.6851.83 60 NP63.8341.47 54Powered by Capital Market - Live News